2m 2m 2m 2m 2m 2m 2m
GT Biopharma (GTBP)
NASDAQ
$4.10+$0.15 (+3.77%)
Price as of Nov 12, 2026 7:57 AM EST- $8.1MMarket Cap
- -78.21%1-Year Change
- BiotechnologyIndustry
GT Biopharma (GTBP)
$4.10+$0.15 (+3.77%)
GTBP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.95 | ||
Change | -$0.010 (-0.25%) | ||
Open | $4.03 | ||
High | $4.03 | ||
Low | $3.86 | ||
Previous Close | $3.96 | ||
Volume | 28,912 | ||
30-Day Average Volume | 69,174 | ||
1-Week Change | -18.39% | ||
1-Month Change | -40.87% | ||
1-Year Change | -78.21% | ||
3-Year Change | -97.76% | ||
5-Year Change | -99.90% | ||
Fundamentals | |||
Shares Outstanding | 2.1M | ||
Total Assets | $5.8M | ||
Market Cap | $8.1M | ||
Enterprise Value | $3.2M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$4.6M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$4.6M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $3.6M | ||
EPS | -$3.00 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 09/08/2026 | ||
Earnings & Revenue